RLAY Relay Therapeutics Inc
Company Analysis
Latest News
Relay Therapeutics target raised to $31, Goldman cites clinical pipeline progress
Goldman Sachs analyst Salveen Richter increased the price target for Relay Therapeutics to $31. The previous target was $22. Richter also reiterated a Buy...
🟢 Relay Therapeutics is trading 4.6% up today on positive clinical data and analyst upgrades
Relay Therapeutics is trading at $20.07 (4.6% up) in after-hours trading as investors continue to respond to positive clinical data and analyst price target...
🟢 Relay Therapeutics is trading 4.1% up today on positive clinical data and analyst price target hikes
Relay Therapeutics is trading 4.1% up today at $20.17 as investors continue to digest positive clinical data and subsequent analyst upgrades. • The rally...
🔴 Relay Therapeutics is trading 6.9% down today amid a broader pullback in high-beta biotech names
Relay Therapeutics is trading 6.9% down today at $18.64 amid a broader pullback in high-beta biotech names. • The drop appears driven by sector-wide...
🟢 Relay Therapeutics surges 4.44% on JPMorgan 'Overweight' initiation and analyst upgrades
• JPMorgan initiated coverage of Relay Therapeutics with an 'Overweight' rating and a $28.00 price target. • H.C. Wainwright raised its price target to $28.00,...
🔴 Relay Therapeutics is trading 5.1% down today as recent analyst-driven momentum cools
Relay Therapeutics is trading 5.1% down at $18.63 following a pre-market pullback from its previous close of $19.63. • The stock appears to be undergoing a...
Relay Therapeutics rated Overweight at JPMorgan, citing $8.3 billion drug potential
JPMorgan initiated coverage on Relay Therapeutics with an Overweight rating. The bank set a price target of $28.00 for the stock. Analysts based the positive...
🔴 RLAY is trading 4.8% down today after announcing a $175M public stock offering
RLAY is trading 4.8% down at $18.80 following the company's announcement of a $175 million underwritten public offering of common stock. • The sizeable equity...
🟢 RLAY is trading 4.4% up today extending momentum from recent clinical data
RLAY is trading at $19.73 (4.4% up), extending its multi-day rebound as momentum continues from prior positive clinical data on zovegalisib. • The stock is...
🔴 RLAY extends move to 5.5% down
RLAY is trading at $17.68, down 5.5% versus the comparison close of $18.71 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 RLAY extends move to 5.2% down
RLAY is trading at $18.72, down 5.2% versus the comparison close of $19.74 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 RLAY is trading 4% down today on profit-taking after its recent equity offering-fueled rally
RLAY is trading 4% down at $18.95 as the stock sees profit-taking and digestion following a sharp multi-week rally driven by positive clinical data and a large...
🟢 RLAY extends move to 5.3% up
RLAY is trading at $19.55, up 5.3% versus the comparison close of $18.56 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 RLAY is trading 4.2% up today on Russell 3000E Growth Benchmark inclusion, extending multi-week rally
RLAY is trading 4.2% up now at $19.34, extending a strong multi-week rally. • Today's upward movement is driven by the company's inclusion in the Russell...
🟢 RLAY is trading 4.1% up today, extending a multi-day rally following its $275M equity offering
RLAY is trading 4.1% up at $18.76, continuing a strong multi-day rally that began earlier in June. • The upward move follows a recently announced $275 million...
🟢 RLAY extends move to 5.2% up
RLAY is trading at $18.34, up 5.2% versus the comparison close of $17.44 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 RLAY is trading 4.5% up today as biotech momentum continues
RLAY is trading 4.5% up at $18.22 as the stock extends a multi-day rebound driven by improving sentiment toward biotech and growth names. • Shares have...
🟢 Relay Therapeutics Inc extends move to 5.6% up
RLAY is trading at $16.77, up 5.6% versus the comparison close of $15.88 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Relay Therapeutics Inc is trading 4.2% up today as shares stabilize following a recent profit-taking pullback
Relay Therapeutics Inc is trading 4.2% up at $16.21, rebounding intraday after opening-weaker price action and yesterday’s profit-taking headline. • The move...
🔴 Relay Therapeutics Inc is trading 6.5% down today on profit-taking after recent gains
Relay Therapeutics Inc is trading 6.5% down at $14.55 in pre-market as the stock undergoes a position reset following a significant multi-day rally. • Shares...